The University of Chicago Header Logo

Connection

Gini Fleming to Neoplasms, Cystic, Mucinous, and Serous

This is a "connection" page, showing publications Gini Fleming has written about Neoplasms, Cystic, Mucinous, and Serous.
  1. Impact of veliparib, paclitaxel dosing regimen, and germline BRCA status on the primary treatment of serous ovarian cancer - an ancillary data analysis of the VELIA trial. Gynecol Oncol. 2022 02; 164(2):278-287.
    View in: PubMed
    Score: 0.196
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.